Investors seeking healthcare sector exposure often evaluate specialized exchange-traded funds (ETFs) that address different aspects of medical innovation and equipment. ARK Genomic Revolution ETF (ARKG) and iShares U.S. Medical Devices ETF (IHI) do not compete directly but provide alternative strategies within the broader healthcare universe. ARKG pursues an active thematic approach centered on genomic technologies, while IHI delivers passive exposure to medical devices. This comparison highlights structural distinctions, exposure profiles, and positioning considerations relevant amid ongoing advancements in biotechnology and healthcare infrastructure.
ARK Genomic Revolution ETF (ARKG) is an actively managed ETF launched in 2014 that seeks long-term capital growth by investing primarily in equity securities of companies involved in the genomics revolution. The fund holds approximately 32 positions and allocates heavily to healthcare, with top holdings including 10x Genomics Inc (TXG), Twist Bioscience Corp (TWST), Tempus AI Inc (TEM), CRISPR Therapeutics AG (CRSP), and Illumina Inc (ILMN). Its expense ratio stands at 0.75%. The strategy emphasizes innovative areas such as gene editing, molecular diagnostics, and bioinformatics, resulting in a concentrated, high-conviction portfolio without a specific index benchmark.
iShares U.S. Medical Devices ETF (IHI) is a passive ETF launched in 2006 that seeks to track the performance of the Dow Jones U.S. Select Medical Equipment Index. The fund holds approximately 45-51 securities focused exclusively on U.S. medical device and equipment companies. Top holdings typically include Abbott Laboratories (ABT), Intuitive Surgical Inc (ISRG), Medtronic PLC (MDT), Stryker Corp (SYK), and Becton Dickinson and Co (BDX). Its expense ratio is 0.37%. The strategy employs quarterly rebalancing to maintain index alignment, providing diversified exposure within the healthcare equipment subsector.
The healthcare sector encompasses distinct sub-industries, including biotechnology, genomics, and medical devices, each influenced by regulatory approvals, technological advancements, reimbursement policies, and demographic trends such as aging populations. Medical device manufacturers benefit from steady demand for diagnostic and therapeutic equipment, while genomics firms face higher volatility tied to clinical trial outcomes and innovation cycles. Macroeconomic factors including interest rate environments and healthcare spending patterns affect capital flows across both areas. Regulatory developments in the United States and globally continue to shape innovation timelines and market access for companies in these fields.
Over recent market cycles, ARK Genomic Revolution ETF (ARKG) has exhibited higher volatility consistent with its active thematic focus on emerging genomics technologies, with performance driven by individual company developments in gene editing and diagnostics. In contrast, iShares U.S. Medical Devices ETF (IHI) has demonstrated more stable behavior linked to established medical equipment leaders, benefiting from consistent revenue streams in device manufacturing. Relative positioning reflects differences in risk exposure, with ARKG offering greater sensitivity to biotechnology breakthroughs and IHI providing steadier participation in healthcare infrastructure trends. Both ETFs respond to sector rotation patterns and broader healthcare spending dynamics across multiple quarters.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors seeking data-driven insights into ETFs like ARK Genomic Revolution ETF (ARKG) or iShares U.S. Medical Devices ETF (IHI) may find the platform useful for refining their research process.
Based on structural characteristics including lower expense ratio, passive indexing methodology, broader holdings diversification within a stable subsector, and consistent liquidity profile, Tickeron’s AI would currently assign a higher probability of favor to iShares U.S. Medical Devices ETF (IHI) for investors prioritizing cost efficiency and sector stability over high-conviction thematic exposure. ARK Genomic Revolution ETF (ARKG) may appeal in environments emphasizing genomics innovation momentum, though its active management and higher fees introduce additional considerations for risk-adjusted positioning.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ARKG saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 04, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 50 instances where the indicator turned negative. In 47 of the 50 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARKG as a result. In 73 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
ARKG moved below its 50-day moving average on November 02, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ARKG crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 22 of 22 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARKG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
ARKG broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ARKG entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for ARKG's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARKG advanced for three days, in 249 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
IHI broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 31 similar instances where the stock broke above the upper band. In 27 of the 31 cases the stock fell afterwards. This puts the odds of success at 87%.
The 10-day RSI Indicator for IHI moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 23 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IHI as a result. In 72 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for IHI turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 45 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IHI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
IHI moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IHI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
The 50-day moving average for IHI moved above the 200-day moving average on November 10, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where IHI advanced for three days, in 234 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Aroon Indicator entered an Uptrend today. In 220 of 292 cases where IHI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
| ARKG | IHI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 85% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 75% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Advances ODDS (%) | 13 days ago 90% | 24 days ago 83% |
| Declines ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 75% |
A.I.dvisor indicates that over the last year, ARKG has been loosely correlated with DNA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ARKG jumps, then DNA could also see price increases.
| Ticker / NAME | Correlation To ARKG | 1D Price Change % | ||
|---|---|---|---|---|
| ARKG | 100% | -5.64% | ||
| DNA - ARKG | 62% Loosely correlated | -9.02% | ||
| FATE - ARKG | 60% Loosely correlated | -9.01% | ||
| PHR - ARKG | 59% Loosely correlated | -3.88% | ||
| EDIT - ARKG | 59% Loosely correlated | -4.09% | ||
| BFLY - ARKG | 58% Loosely correlated | -7.69% | ||
More | ||||
A.I.dvisor indicates that over the last year, IHI has been closely correlated with SYK. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if IHI jumps, then SYK could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SRTY | 33.09 | 2.56 | +8.39% |
| ProShares UltraPro Short Russell2000 (SRTY) | |||
| FMHI | 45.87 | 0.04 | +0.10% |
| First Trust Municipal High Income ETF (FMHI) | |||
| GLO | 5.06 | -0.14 | -2.69% |
| Clough Global Opportunities Fund | |||
| LBAY | 26.92 | -0.95 | -3.42% |
| Leatherback Long/Short Alternative Yield ETF (LBAY) | |||
| MEGX | 16.09 | -2.96 | -15.53% |
| Corgi U.S. Mega-Cap Growth 2x Daily ETF (MEGX) | |||